March 3, 2020 / 12:14 PM / a month ago

BRIEF-Sierra Oncology Reports Qtrly Loss Per Share $7.88

March 3 (Reuters) - Sierra Oncology Inc:

* SIERRA ONCOLOGY REPORTS 2019 YEAR END RESULTS

* SIERRA ONCOLOGY - ANTICIPATES CURRENT RESOURCES TO BE SUFFICIENT FOR DEVELOPMENT STRATEGY FOR MOMELOTINIB INTO H2 2022

* SIERRA ONCOLOGY INC QTRLY LOSS PER SHARE $7.88

* SIERRA ONCOLOGY INC QTRLY NON-GAAP ADJUSTED LOSS PER SHARE $2.51 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below